VSE Capital Markets

Quarterly Result

Divis Laboratories Ltd

NSE : DIVISLABBSE : 532488ISIN CODE : INE361B01024Industry : Pharmaceuticals - Indian - Bulk Drugs

Particulars	Sep 2021(₹ Cr)	Jun 2021(₹ Cr)	Mar 2021(₹ Cr)	Dec 2020(₹ Cr)	Sep 2020(₹ Cr)	Jun 2020(₹ Cr)
Gross Sales	1967.86	1950.16	1718.39	1656.48	1713.78	1709.96
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	1967.86	1950.16	1718.39	1656.48	1713.78	1709.96
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	19.11	35.55	22.85	19.68	13.64	17.87
Total Income	1986.97	1985.71	1741.24	1676.16	1727.42	1727.83
Total Expenditure	1149.27	1098.69	1019.04	978.03	981.39	1010.98
PBIDT	837.70	887.02	722.20	698.13	746.03	716.85
Interest	0.17	0.24	0.18	0.22	0.11	0.18
PBDT	837.53	886.78	722.02	697.91	745.92	716.67
Depreciation	77.09	73.01	69.84	67.95	60.89	55.97
Tax	133.83	239.48	135.40	142.76	144.41	186.48
Fringe Benefit Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	20.22	22.32	28.85	25.96	27.32	-18.03
Reported Profit After Tax	606.39	551.97	487.93	461.24	513.30	492.25
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	606.39	551.97	487.93	461.24	513.30	492.25

EPS (Unit Curr.)	22.84	20.79	18.38	17.37	19.34	18.54
EPS (Adj) (Unit Curr.)	22.84	20.79	18.38	17.37	19.34	18.54
Calculated EPS (Unit Curr.)	22.84	20.79	18.38	17.38	19.34	18.54
Calculated EPS (Adj) (Unit Curr.)	22.84	20.79	18.38	17.38	19.34	18.54
Calculated EPS (Ann.) (Unit Curr.)	91.38	83.17	73.52	69.50	77.35	74.18
Calculated EPS (Adj) (Ann.) (Unit Curr.)	91.38	83.17	73.52	69.50	77.35	74.18
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	53.09	53.09	53.09	53.09	53.09	53.09
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	2.00	2.00	2.00	2.00	2.00	2.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	42.57	45.48	42.03	42.15	43.53	41.92
PBDTM(%)	42.56	45.47	42.02	42.13	43.52	41.91
PATM(%)	30.81	28.30	28.39	27.84	29.95	28.79

3rd Floor,Fortune Tower,Sayajigunj, Vadodara 390020, Gujarat, India

Telephone: +91 265 2361534

Customer Care Number: +91 265 2361474

Customer Care Timings: Monday to Friday 8:30am to 6:15pm

Email Address: vse@vselindia.com / compliance@vselindia.com

Attention Investors:

"Prevent Unauthorized transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day .......... Issued in the interest of investors
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
KYC is one time exercise while dealing in securities market - once KYC is done through a SEBI registered intermediary (broker , DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.
Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

For any complaints pertaining to securities broking please write to compliance@vselindia.com, for DP related to dp@vselindia.com. Please ensure you carefully read the Risk Disclosure Document as prescribed by SEBI.

Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed.